Ratings by Canaccord (John Newman)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/4/2026 | Compass Therapeutics | CMPX | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2026 | Atara Biotherapeutics | ATRA | Downgrade | Hold (Buy) |
5.88 (5.17) |
-12.07% | Details | |
| 1/6/2026 | Adicet Bio Inc. | ACET | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2025 | Atara Biotherapeutics | ATRA | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2025 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2025 | Compass Therapeutics | CMPX | New Coverage | Buy (N/A) |
5.22 (5.51) |
5.56% | Details | |
| 11/12/2025 | Nuvalent | NUVL | New Coverage | Buy (N/A) |
96.16 (99.41) |
3.38% | Details | |
| 11/3/2025 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2025 | Regeneron Pharma | REGN | Maintain | Buy (Buy) |
|
Details | ||
| 9/24/2025 | Seres Therapeutics | MCRB | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2025 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2025 | Marker Therapeutics | MRKR | New Coverage | Buy (N/A) |
1.38 (1.38) |
0% | Details | |
| 2/26/2025 | Candel Therapeutics Inc. | CADL | Maintain | Buy (N/A) |
|
Details | ||
| 2/19/2025 | Candel Therapeutics Inc. | CADL | New Coverage | Buy (N/A) |
9.52 (4.94) |
-48.11% | Details | |
| 1/17/2025 | Atara Biotherapeutics | ATRA | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2024 | Atara Biotherapeutics | ATRA | Maintain | Buy (N/A) |
|
Details | ||
| 10/23/2024 | Ocuphire | OCUP | Maintain | Buy (N/A) |
|
Details | ||
| 9/11/2024 | Adicet Bio Inc. | ACET | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2024 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 7/2/2024 | Cartesian Therapeutics | RNAC | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2024 | Aptose Biosciences | APTO | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2024 | Ocuphire | OCUP | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2024 | 2Seventy Bio Inc. | TSVT | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2024 | Aptose Biosciences | APTO | Maintain | Buy (N/A) |
|
Details | ||
| 2/29/2024 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2024 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2024 | Adicet Bio Inc. | ACET | Maintain | Buy (N/A) |
|
Details | ||
| 11/30/2023 | Immunogen Inc. | IMGN | Downgrade | Hold (Buy) |
16.06 (31.25) |
94.58% | Details | |
| 11/15/2023 | 2Seventy Bio Inc. | TSVT | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | Atara Biotherapeutics | ATRA | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | Adicet Bio Inc. | ACET | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2023 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2023 | Atara Biotherapeutics | ATRA | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2023 | Regeneron Pharma | REGN | Upgrade | Buy (Hold) |
812.40 (759.86) |
-6.47% | Details | |
| 8/1/2023 | Immunogen Inc. | IMGN | Maintain | Buy (N/A) |
|
Details | ||
| 7/27/2023 | Immunogen Inc. | IMGN | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2023 | Regeneron Pharma | REGN | Downgrade | Hold (Buy) |
784.38 (759.86) |
-3.13% | Details | |
| 6/5/2023 | Immunogen Inc. | IMGN | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2023 | Atara Biotherapeutics | ATRA | Maintain | Buy (N/A) |
|
Details | ||
| 4/19/2023 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2023 | Aptose Biosciences | APTO | Maintain | Buy (N/A) |
|
Details | ||
| 3/21/2023 | Seres Therapeutics | MCRB | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2023 | Histogen Inc. | HSTO | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2023 | Seres Therapeutics | MCRB | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2023 | Oncolytics Biotech | ONCY | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2023 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2023 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2022 | Arcellx Inc. | ACLX | Maintain | Buy (N/A) |
|
Details | ||
| 11/16/2022 | Immunogen Inc. | IMGN | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2022 | Ocuphire | OCUP | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2022 | Selecta Biosciences | SELB | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Global Blood Therapeutics | GBT | Upgrade | Buy (Hold) |
63.84 (68.49) |
7.28% | Details | |
| 8/4/2022 | Seres Therapeutics | MCRB | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2022 | Arcellx Inc. | ACLX | New Coverage | Buy (N/A) |
18.27 (114.33) |
525.78% | Details | |
| 5/5/2022 | Seres Therapeutics | MCRB | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | Atara Biotherapeutics | ATRA | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2022 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2022 | Oncolytics Biotech | ONCY | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2021 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2021 | 2Seventy Bio Inc. | TSVT | New Coverage | Buy (N/A) |
32.66 (5.00) |
-84.69% | Details | |
| 11/8/2021 | bluebird bio | BLUE | Maintain | Hold (N/A) |
|
Details | ||
| 8/12/2021 | Histogen Inc. | HSTO | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2021 | bluebird bio | BLUE | Downgrade | Hold (Buy) |
18.16 (4.97) |
-72.63% | Details | |
| 7/30/2021 | Atreca Inc. | BCEL | Maintain | Buy (N/A) |
|
Details | ||
| 7/23/2021 | Seres Therapeutics | MCRB | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2021 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2021 | Adicet Bio Inc. | ACET | New Coverage | Buy (N/A) |
12.71 (7.29) |
-42.64% | Details | |
| 3/16/2021 | Ocuphire | OCUP | Maintain | Buy (Buy) |
|
Details | ||
| 2/17/2021 | Sesen Bio, Inc | SESN | Maintain | Buy (Buy) |
|
Details | ||
| 2/10/2021 | Ocuphire | OCUP | New Coverage | Buy (N/A) |
10.57 (1.17) |
-88.93% | Details | |
| 1/25/2021 | Sesen Bio, Inc | SESN | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2020 | Sesen Bio, Inc | SESN | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Seres Therapeutics | MCRB | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2020 | Global Blood Therapeutics | GBT | Maintain | Hold (N/A) |
|
Details | ||
| 7/8/2020 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2020 | Atreca Inc. | BCEL | Maintain | Buy (N/A) |
|
Details | ||
| 5/14/2020 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2020 | Regeneron Pharma | REGN | Upgrade | Buy (Hold) |
442.35 (759.86) |
71.78% | Details | |
| 2/13/2020 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2020 | Palatin Technologies | PTN | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2019 | Palatin Technologies | PTN | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2019 | Global Blood Therapeutics | GBT | New Coverage | Hold (N/A) |
49.79 (68.49) |
37.56% | Details | |
| 11/5/2019 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
| 11/5/2019 | Seres Therapeutics | MCRB | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2019 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
| 9/13/2019 | Palatin Technologies | PTN | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2019 | Atreca Inc. | BCEL | New Coverage | Buy (N/A) |
16.74 (0.09) |
-99.46% | Details | |
| 7/1/2019 | Atara Biotherapeutics | ATRA | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2019 | Palatin Technologies | PTN | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2019 | VBI Vaccines | VBIV | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2019 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
| 4/9/2019 | Aileron Therapeutics Inc | ALRN | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2019 | Kaleido Biosciences Inc. | KLDO | New Coverage | Buy (N/A) |
13.52 (0.00) |
-100% | Details | |
| 3/22/2019 | Atara Biotherapeutics | ATRA | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2019 | Selecta Biosciences | SELB | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2019 | Seres Therapeutics | MCRB | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2019 | Immunomedics | IMMU | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2019 | Immunogen Inc. | IMGN | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2019 | Regeneron Pharma | REGN | Maintain | Hold (N/A) |
|
Details | ||
| 1/24/2019 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 1/23/2019 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 1/4/2019 | Selecta Biosciences | SELB | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2019 | Celgene | CELG | Downgrade | Hold (Buy) |
66.64 (108.24) |
62.42% | Details | |
| 9/26/2018 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details | ||
| 9/26/2018 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details |
